Lercanidipine hydrochloride is a prescription medication mainly used to treat mild to moderate essential hypertension (high blood pressure) in adults. By lowering blood pressure, the medication helps to prevent serious health problems including heart disease, heart attacks, and strokes. It can be used as a standalone treatment (monotherapy) or in combination with other blood pressure medications like ACE inhibitors or diuretics. It is grouped under the following drug class(es): Vasodilating agents. Its therapeutic use is listed as cardiovascular. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Cardiovasc, Corifeo, Lercan, Renovia and Vasodip. Its PubChem CID is 157917.
Lercanidipine hydrochloride
| CAS No | 132866-11-6 |
|---|---|
| Molecular Formula | C36H42ClN3O6 |
| Molecular Weight | 648.20 g/mol |
| Synonyms | 5-O-[1-[3,3-diphenylpropyl(methyl)amino]-2-methylpropan-2-yl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Lercanidipine hydrochloride is a prescription medication mainly used to treat mild to moderate essential hypertension (high blood pressure) in adults. By lowering blood pressure, the medication helps to prevent serious health problems including heart disease, heart attacks, and strokes.
The listed CAS number is 132866-11-6.
The listed molecular formula is C36H42ClN3O6.
The listed molecular weight is 648.20 g/mol.
5-O-[1-[3,3-diphenylpropyl(methyl)amino]-2-methylpropan-2-yl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;hydrochloride.
The source lists Cardiovasc, Corifeo, Lercan, Renovia and Vasodip.